NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
4.890
-0.070 (-1.41%)
At close: Aug 1, 2025, 4:00 PM
4.820
-0.070 (-1.43%)
After-hours: Aug 1, 2025, 7:44 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $13.09 million as of August 1, 2025. Its market cap has decreased by -73.72% in one year.
Market Cap
13.09M
Enterprise Value
-36.93M
1-Year Change
-73.72%
Ranking
Category
Stock Price
$4.89
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $13.09M, a decrease of -97.00%. That is a compound annual growth rate of -43.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 13.27M | -38.53% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | 300.33M | -80.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |